| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endometrium | 12 | 2024 | 277 | 1.160 |
Why?
|
| Nuclear Receptor Coactivator 3 | 7 | 2023 | 259 | 0.880 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 10 | 2016 | 325 | 0.840 |
Why?
|
| Receptors, Progesterone | 12 | 2024 | 682 | 0.810 |
Why?
|
| Receptors, Steroid | 4 | 2024 | 176 | 0.720 |
Why?
|
| Polyploidy | 1 | 2021 | 18 | 0.720 |
Why?
|
| Giant Cells | 1 | 2021 | 35 | 0.710 |
Why?
|
| Transcription, Genetic | 15 | 2018 | 1423 | 0.700 |
Why?
|
| Ovarian Neoplasms | 2 | 2021 | 462 | 0.650 |
Why?
|
| Gene Expression Regulation | 11 | 2025 | 2442 | 0.580 |
Why?
|
| Decidua | 7 | 2019 | 138 | 0.570 |
Why?
|
| Repressor Proteins | 9 | 2018 | 813 | 0.560 |
Why?
|
| Estrogen Receptor alpha | 7 | 2021 | 439 | 0.530 |
Why?
|
| RNA, Untranslated | 4 | 2006 | 112 | 0.500 |
Why?
|
| Nuclear Receptor Coactivator 2 | 4 | 2018 | 148 | 0.470 |
Why?
|
| Trans-Activators | 6 | 2016 | 712 | 0.470 |
Why?
|
| Ovulation | 2 | 2025 | 107 | 0.440 |
Why?
|
| Stromal Cells | 6 | 2019 | 304 | 0.420 |
Why?
|
| Breast Neoplasms | 8 | 2023 | 2681 | 0.420 |
Why?
|
| Mice | 35 | 2025 | 18509 | 0.390 |
Why?
|
| Animals | 47 | 2025 | 34854 | 0.370 |
Why?
|
| Signal Transduction | 18 | 2025 | 4720 | 0.360 |
Why?
|
| Receptors, Glucocorticoid | 7 | 2012 | 106 | 0.360 |
Why?
|
| Progesterone | 6 | 2024 | 451 | 0.330 |
Why?
|
| Proteome | 2 | 2011 | 279 | 0.320 |
Why?
|
| Embryo Implantation | 4 | 2019 | 231 | 0.300 |
Why?
|
| SOXF Transcription Factors | 3 | 2023 | 18 | 0.290 |
Why?
|
| Transcriptome | 7 | 2020 | 1125 | 0.290 |
Why?
|
| Luteinizing Hormone | 2 | 2025 | 136 | 0.280 |
Why?
|
| Ovary | 3 | 2025 | 371 | 0.280 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2021 | 2062 | 0.280 |
Why?
|
| Uterus | 4 | 2018 | 548 | 0.260 |
Why?
|
| Transcriptional Activation | 7 | 2024 | 430 | 0.260 |
Why?
|
| Transfection | 12 | 2016 | 996 | 0.260 |
Why?
|
| Receptor, ErbB-2 | 3 | 2021 | 549 | 0.250 |
Why?
|
| Estrogens | 4 | 2024 | 436 | 0.250 |
Why?
|
| Binding Sites | 10 | 2018 | 1256 | 0.250 |
Why?
|
| Receptors, Androgen | 5 | 2014 | 410 | 0.250 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2008 | 361 | 0.240 |
Why?
|
| HMGB Proteins | 2 | 2018 | 9 | 0.240 |
Why?
|
| Databases, Protein | 1 | 2006 | 62 | 0.240 |
Why?
|
| Luteinization | 1 | 2025 | 12 | 0.230 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2025 | 15 | 0.230 |
Why?
|
| RNA, Long Noncoding | 6 | 2018 | 240 | 0.230 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2025 | 43 | 0.230 |
Why?
|
| Semaphorins | 1 | 2025 | 33 | 0.230 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2025 | 39 | 0.230 |
Why?
|
| Granulosa Cells | 2 | 2025 | 140 | 0.230 |
Why?
|
| Chromatin Immunoprecipitation | 7 | 2015 | 236 | 0.230 |
Why?
|
| Chromatin | 5 | 2018 | 520 | 0.220 |
Why?
|
| Adipocytes | 2 | 2018 | 182 | 0.220 |
Why?
|
| Gene Regulatory Networks | 2 | 2017 | 387 | 0.220 |
Why?
|
| Neovascularization, Physiologic | 1 | 2025 | 210 | 0.210 |
Why?
|
| Hormones | 2 | 2020 | 170 | 0.210 |
Why?
|
| Myocardium | 3 | 2024 | 907 | 0.210 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 118 | 0.200 |
Why?
|
| Immunoprecipitation | 4 | 2011 | 196 | 0.200 |
Why?
|
| Fibroblasts | 3 | 2024 | 862 | 0.200 |
Why?
|
| Endometriosis | 2 | 2024 | 175 | 0.200 |
Why?
|
| Cell Proliferation | 7 | 2021 | 2511 | 0.200 |
Why?
|
| Transcription Factors | 7 | 2016 | 2491 | 0.200 |
Why?
|
| Tamoxifen | 3 | 2023 | 354 | 0.190 |
Why?
|
| Protein Binding | 10 | 2018 | 1734 | 0.190 |
Why?
|
| Protein Interaction Mapping | 3 | 2011 | 92 | 0.190 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2023 | 134 | 0.190 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2023 | 138 | 0.190 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2018 | 1018 | 0.180 |
Why?
|
| Apoptosis | 3 | 2024 | 1901 | 0.180 |
Why?
|
| GATA2 Transcription Factor | 3 | 2018 | 46 | 0.180 |
Why?
|
| Female | 30 | 2025 | 70787 | 0.180 |
Why?
|
| Early Growth Response Protein 1 | 2 | 2019 | 38 | 0.180 |
Why?
|
| RNA | 3 | 2003 | 552 | 0.180 |
Why?
|
| Mass Spectrometry | 3 | 2011 | 356 | 0.170 |
Why?
|
| Forkhead Box Protein O1 | 2 | 2018 | 97 | 0.170 |
Why?
|
| Promyelocytic Leukemia Zinc Finger Protein | 2 | 2018 | 12 | 0.170 |
Why?
|
| Gene Expression Profiling | 4 | 2020 | 1883 | 0.170 |
Why?
|
| Mitosis | 1 | 2021 | 199 | 0.170 |
Why?
|
| Humans | 44 | 2024 | 132247 | 0.170 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2021 | 75 | 0.170 |
Why?
|
| HeLa Cells | 7 | 2013 | 731 | 0.160 |
Why?
|
| RNA-Binding Proteins | 4 | 2018 | 608 | 0.160 |
Why?
|
| DNA | 8 | 2016 | 1479 | 0.160 |
Why?
|
| Base Sequence | 8 | 2016 | 2900 | 0.160 |
Why?
|
| Estradiol | 5 | 2020 | 488 | 0.160 |
Why?
|
| Polymerase Chain Reaction | 4 | 2010 | 1555 | 0.160 |
Why?
|
| Neoplasm Proteins | 1 | 2024 | 702 | 0.160 |
Why?
|
| Oxidative Stress | 1 | 2024 | 801 | 0.150 |
Why?
|
| Mice, Transgenic | 7 | 2020 | 2451 | 0.150 |
Why?
|
| Carrier Proteins | 2 | 2016 | 1050 | 0.150 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 3 | 2021 | 44 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 1 | 2025 | 1134 | 0.150 |
Why?
|
| Aldose-Ketose Isomerases | 1 | 2018 | 10 | 0.150 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2018 | 41 | 0.150 |
Why?
|
| RNA Interference | 4 | 2018 | 515 | 0.150 |
Why?
|
| Cell Line, Tumor | 8 | 2021 | 3691 | 0.150 |
Why?
|
| Histone Acetyltransferases | 4 | 2015 | 227 | 0.150 |
Why?
|
| RNA Polymerase III | 1 | 2018 | 41 | 0.140 |
Why?
|
| Mice, Knockout | 8 | 2023 | 3868 | 0.140 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2016 | 118 | 0.140 |
Why?
|
| Molecular Sequence Data | 8 | 2015 | 3771 | 0.140 |
Why?
|
| Adipogenesis | 1 | 2018 | 80 | 0.140 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2016 | 816 | 0.140 |
Why?
|
| MicroRNAs | 2 | 2016 | 916 | 0.140 |
Why?
|
| Fertility | 2 | 2014 | 260 | 0.140 |
Why?
|
| Multiprotein Complexes | 3 | 2015 | 201 | 0.130 |
Why?
|
| Promoter Regions, Genetic | 7 | 2021 | 1284 | 0.130 |
Why?
|
| Prostatic Neoplasms | 2 | 2016 | 1577 | 0.130 |
Why?
|
| Cells, Cultured | 7 | 2019 | 3046 | 0.130 |
Why?
|
| RNA, Small Interfering | 5 | 2018 | 689 | 0.130 |
Why?
|
| Spermatogonia | 1 | 2017 | 33 | 0.130 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1995 | 357 | 0.130 |
Why?
|
| Cell Line | 7 | 2010 | 2724 | 0.130 |
Why?
|
| Glucocorticoids | 3 | 2012 | 387 | 0.130 |
Why?
|
| Stem Cell Niche | 1 | 2017 | 58 | 0.130 |
Why?
|
| Cell Differentiation | 7 | 2018 | 1965 | 0.120 |
Why?
|
| E2F1 Transcription Factor | 1 | 2016 | 50 | 0.120 |
Why?
|
| Computational Biology | 3 | 2018 | 876 | 0.120 |
Why?
|
| Gene Targeting | 1 | 2016 | 173 | 0.120 |
Why?
|
| Metabolome | 2 | 2018 | 324 | 0.120 |
Why?
|
| Germ Cells | 1 | 2016 | 204 | 0.110 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2015 | 52 | 0.110 |
Why?
|
| Interferon Regulatory Factors | 1 | 2015 | 43 | 0.110 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2014 | 41 | 0.110 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2014 | 61 | 0.110 |
Why?
|
| DNA-Binding Proteins | 3 | 2017 | 1997 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2016 | 491 | 0.110 |
Why?
|
| Genome | 3 | 2012 | 504 | 0.100 |
Why?
|
| Phosphorylation | 2 | 2016 | 1612 | 0.100 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2014 | 94 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2013 | 1080 | 0.100 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2013 | 12 | 0.100 |
Why?
|
| Abortion, Spontaneous | 1 | 2014 | 84 | 0.100 |
Why?
|
| COUP Transcription Factor II | 1 | 2013 | 98 | 0.100 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2014 | 165 | 0.100 |
Why?
|
| Amino Acid Sequence | 6 | 2011 | 2669 | 0.100 |
Why?
|
| Cell Division | 3 | 2003 | 744 | 0.100 |
Why?
|
| Steroids | 2 | 2024 | 174 | 0.100 |
Why?
|
| Nuclear Proteins | 4 | 2018 | 1285 | 0.100 |
Why?
|
| ErbB Receptors | 1 | 2014 | 296 | 0.100 |
Why?
|
| Ribonuclease III | 1 | 2013 | 99 | 0.100 |
Why?
|
| Ligands | 4 | 2023 | 495 | 0.100 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2012 | 41 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 387 | 0.090 |
Why?
|
| Mutation | 6 | 2011 | 6250 | 0.090 |
Why?
|
| Prostate | 1 | 2014 | 437 | 0.090 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 147 | 0.090 |
Why?
|
| Stem Cells | 1 | 2017 | 733 | 0.090 |
Why?
|
| Genome, Human | 4 | 2015 | 1331 | 0.090 |
Why?
|
| Phorbols | 2 | 1982 | 5 | 0.090 |
Why?
|
| Ornithine Decarboxylase | 2 | 1982 | 18 | 0.090 |
Why?
|
| Proteomics | 2 | 2016 | 596 | 0.090 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1982 | 63 | 0.090 |
Why?
|
| Prostaglandins | 2 | 1982 | 43 | 0.090 |
Why?
|
| Carboxy-Lyases | 2 | 1982 | 13 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2023 | 1866 | 0.090 |
Why?
|
| Response Elements | 4 | 2015 | 98 | 0.090 |
Why?
|
| Circadian Rhythm | 1 | 2014 | 316 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 1541 | 0.090 |
Why?
|
| Rats | 6 | 2024 | 3607 | 0.090 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2002 | 261 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2018 | 1597 | 0.080 |
Why?
|
| Heart Atria | 1 | 2013 | 337 | 0.080 |
Why?
|
| Protein Structure, Tertiary | 5 | 2015 | 764 | 0.080 |
Why?
|
| RNA Polymerase II | 1 | 2010 | 87 | 0.080 |
Why?
|
| Software | 3 | 2015 | 732 | 0.080 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2018 | 291 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 6 | 2017 | 4758 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 551 | 0.080 |
Why?
|
| Cell Nucleus | 2 | 2018 | 592 | 0.070 |
Why?
|
| Proteins | 2 | 2011 | 1038 | 0.070 |
Why?
|
| Protein Conformation | 3 | 2015 | 826 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 1683 | 0.070 |
Why?
|
| Cell Lineage | 2 | 2021 | 358 | 0.070 |
Why?
|
| Cloning, Molecular | 3 | 2017 | 811 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2012 | 590 | 0.070 |
Why?
|
| Up-Regulation | 2 | 2014 | 881 | 0.070 |
Why?
|
| Internet | 2 | 2009 | 406 | 0.060 |
Why?
|
| Wnt Proteins | 2 | 2018 | 224 | 0.060 |
Why?
|
| Transcriptional Regulator ERG | 2 | 2016 | 39 | 0.060 |
Why?
|
| Hedgehog Proteins | 2 | 2018 | 263 | 0.060 |
Why?
|
| DNA, Complementary | 2 | 1999 | 454 | 0.060 |
Why?
|
| Systems Integration | 1 | 2006 | 28 | 0.060 |
Why?
|
| In Situ Hybridization | 2 | 2003 | 469 | 0.060 |
Why?
|
| Inflammation | 1 | 2013 | 1522 | 0.060 |
Why?
|
| Metabolic Diseases | 1 | 2007 | 139 | 0.060 |
Why?
|
| Time Factors | 4 | 2017 | 6451 | 0.060 |
Why?
|
| Serum Response Factor | 1 | 2004 | 29 | 0.060 |
Why?
|
| Male | 10 | 2023 | 65014 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2018 | 1045 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2017 | 679 | 0.060 |
Why?
|
| User-Computer Interface | 1 | 2006 | 168 | 0.060 |
Why?
|
| Organ Specificity | 2 | 2017 | 412 | 0.060 |
Why?
|
| Heme Oxygenase-1 | 1 | 2024 | 29 | 0.050 |
Why?
|
| Pregnancy | 4 | 2019 | 7557 | 0.050 |
Why?
|
| Sequence Analysis, RNA | 2 | 2018 | 409 | 0.050 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 2003 | 24 | 0.050 |
Why?
|
| Sexual Behavior, Animal | 1 | 2003 | 63 | 0.050 |
Why?
|
| Nuclear Receptor Coactivator 1 | 2 | 2006 | 162 | 0.050 |
Why?
|
| Ethynodiol Diacetate | 1 | 2003 | 2 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2003 | 252 | 0.050 |
Why?
|
| Consensus Sequence | 2 | 2014 | 57 | 0.050 |
Why?
|
| Endocardium | 1 | 2023 | 54 | 0.050 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2007 | 459 | 0.050 |
Why?
|
| Neuropeptides | 1 | 2003 | 117 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2003 | 380 | 0.050 |
Why?
|
| Mammary Glands, Human | 1 | 2003 | 81 | 0.050 |
Why?
|
| Base Pairing | 1 | 2002 | 42 | 0.050 |
Why?
|
| Plasmids | 3 | 2013 | 459 | 0.050 |
Why?
|
| Fibrosis | 1 | 2024 | 421 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2003 | 422 | 0.050 |
Why?
|
| RNA, Messenger | 4 | 2013 | 2680 | 0.050 |
Why?
|
| Transgenes | 1 | 2003 | 336 | 0.050 |
Why?
|
| Nucleic Acid Conformation | 1 | 2002 | 182 | 0.050 |
Why?
|
| Cell Survival | 1 | 2024 | 868 | 0.050 |
Why?
|
| Species Specificity | 1 | 2002 | 542 | 0.050 |
Why?
|
| Models, Molecular | 2 | 2002 | 1120 | 0.050 |
Why?
|
| Reproduction | 1 | 2003 | 226 | 0.050 |
Why?
|
| GATA3 Transcription Factor | 1 | 2021 | 43 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2021 | 89 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2023 | 234 | 0.040 |
Why?
|
| Cell Cycle Proteins | 2 | 2016 | 685 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2003 | 472 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2021 | 109 | 0.040 |
Why?
|
| Homeodomain Proteins | 3 | 2013 | 569 | 0.040 |
Why?
|
| Evolution, Molecular | 1 | 2004 | 700 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 1285 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2003 | 771 | 0.040 |
Why?
|
| Tumor Burden | 1 | 2021 | 248 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2014 | 579 | 0.040 |
Why?
|
| Phenotype | 2 | 2014 | 4540 | 0.040 |
Why?
|
| Alleles | 2 | 2017 | 1685 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 1 | 2020 | 327 | 0.040 |
Why?
|
| Cell Adhesion Molecules, Neuron-Glia | 1 | 1998 | 1 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 665 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 1999 | 147 | 0.040 |
Why?
|
| Leukemia Inhibitory Factor | 1 | 2018 | 27 | 0.040 |
Why?
|
| Luciferases | 2 | 2013 | 129 | 0.040 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2018 | 26 | 0.040 |
Why?
|
| Embryoid Bodies | 1 | 2018 | 6 | 0.040 |
Why?
|
| Butyrate Response Factor 1 | 1 | 2018 | 5 | 0.040 |
Why?
|
| Neurites | 1 | 1998 | 45 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 1998 | 69 | 0.040 |
Why?
|
| Heart | 1 | 2023 | 689 | 0.040 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 1998 | 81 | 0.040 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2018 | 34 | 0.040 |
Why?
|
| Dexamethasone | 2 | 2003 | 273 | 0.040 |
Why?
|
| NF-kappa B | 1 | 2000 | 454 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 107 | 0.040 |
Why?
|
| Mesoderm | 1 | 2018 | 107 | 0.040 |
Why?
|
| Carbon Isotopes | 1 | 2018 | 233 | 0.040 |
Why?
|
| Cell Polarity | 1 | 2018 | 125 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 998 | 0.040 |
Why?
|
| Oxidative Phosphorylation | 1 | 2018 | 124 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2021 | 635 | 0.030 |
Why?
|
| Glycolysis | 1 | 2018 | 165 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2019 | 398 | 0.030 |
Why?
|
| Receptors, OSM-LIF | 1 | 2017 | 6 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2015 | 3018 | 0.030 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2017 | 24 | 0.030 |
Why?
|
| Animals, Newborn | 2 | 2017 | 1033 | 0.030 |
Why?
|
| Cell Self Renewal | 1 | 2017 | 49 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2018 | 755 | 0.030 |
Why?
|
| Progestins | 1 | 2016 | 45 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 2016 | 296 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2018 | 295 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2016 | 86 | 0.030 |
Why?
|
| Fos-Related Antigen-2 | 1 | 2015 | 4 | 0.030 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2015 | 21 | 0.030 |
Why?
|
| Neoplasms | 2 | 2016 | 2961 | 0.030 |
Why?
|
| Nucleotide Motifs | 1 | 2015 | 48 | 0.030 |
Why?
|
| Gene Deletion | 2 | 2011 | 794 | 0.030 |
Why?
|
| Chimera | 1 | 1995 | 83 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1995 | 128 | 0.030 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 1994 | 19 | 0.030 |
Why?
|
| Transcription Factor AP-1 | 1 | 2015 | 111 | 0.030 |
Why?
|
| Testis | 1 | 2017 | 423 | 0.030 |
Why?
|
| Mifepristone | 1 | 1994 | 99 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2018 | 613 | 0.030 |
Why?
|
| Wnt4 Protein | 1 | 2014 | 19 | 0.030 |
Why?
|
| Receptor, ErbB-3 | 1 | 2014 | 17 | 0.030 |
Why?
|
| WNK Lysine-Deficient Protein Kinase 1 | 1 | 2014 | 13 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2014 | 39 | 0.030 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2014 | 99 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2016 | 443 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2014 | 87 | 0.030 |
Why?
|
| CLOCK Proteins | 1 | 2014 | 34 | 0.030 |
Why?
|
| Alanine | 1 | 1994 | 158 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 100 | 0.030 |
Why?
|
| Cell Movement | 1 | 2018 | 891 | 0.030 |
Why?
|
| Azepines | 1 | 2014 | 64 | 0.030 |
Why?
|
| ARNTL Transcription Factors | 1 | 2014 | 45 | 0.030 |
Why?
|
| DNA Replication | 1 | 2016 | 353 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2016 | 1050 | 0.030 |
Why?
|
| Choristoma | 1 | 2013 | 46 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 1994 | 122 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2016 | 607 | 0.030 |
Why?
|
| Cell Fractionation | 1 | 2013 | 23 | 0.030 |
Why?
|
| Cryoelectron Microscopy | 1 | 2015 | 243 | 0.030 |
Why?
|
| Triazoles | 1 | 2014 | 147 | 0.030 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2013 | 66 | 0.030 |
Why?
|
| Cell Size | 1 | 2013 | 85 | 0.020 |
Why?
|
| Epigenomics | 1 | 2014 | 191 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 309 | 0.020 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2014 | 256 | 0.020 |
Why?
|
| Support Vector Machine | 1 | 2012 | 23 | 0.020 |
Why?
|
| 3T3-L1 Cells | 1 | 2012 | 58 | 0.020 |
Why?
|
| MCF-7 Cells | 1 | 2013 | 217 | 0.020 |
Why?
|
| Dihydrotestosterone | 1 | 2012 | 72 | 0.020 |
Why?
|
| Androgens | 1 | 2014 | 277 | 0.020 |
Why?
|
| T-Box Domain Proteins | 1 | 2013 | 122 | 0.020 |
Why?
|
| Liver | 2 | 2014 | 1797 | 0.020 |
Why?
|
| Protein Phosphatase 2 | 1 | 2011 | 28 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1995 | 584 | 0.020 |
Why?
|
| Molecular Conformation | 1 | 2011 | 107 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 1128 | 0.020 |
Why?
|
| Molecular Sequence Annotation | 1 | 2012 | 157 | 0.020 |
Why?
|
| Enzyme Induction | 2 | 1982 | 97 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2013 | 441 | 0.020 |
Why?
|
| Pseudopregnancy | 1 | 2011 | 17 | 0.020 |
Why?
|
| Peptides | 1 | 1995 | 844 | 0.020 |
Why?
|
| BRCA1 Protein | 1 | 2011 | 81 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 380 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 1461 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 799 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2014 | 623 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 1045 | 0.020 |
Why?
|
| Action Potentials | 1 | 2013 | 495 | 0.020 |
Why?
|
| Histone Deacetylase 2 | 1 | 2010 | 14 | 0.020 |
Why?
|
| Histone Deacetylase 1 | 1 | 2010 | 20 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2011 | 331 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 541 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4690 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2014 | 937 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2011 | 495 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2011 | 701 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2013 | 785 | 0.020 |
Why?
|
| International Cooperation | 1 | 2009 | 167 | 0.020 |
Why?
|
| Disease Progression | 1 | 2014 | 2233 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2013 | 652 | 0.020 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2006 | 51 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2012 | 1803 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 1829 | 0.020 |
Why?
|
| COS Cells | 1 | 2006 | 268 | 0.020 |
Why?
|
| Prognosis | 1 | 2014 | 5016 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2006 | 615 | 0.010 |
Why?
|
| Models, Biological | 1 | 2010 | 1445 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 2703 | 0.010 |
Why?
|
| Algorithms | 1 | 2011 | 1725 | 0.010 |
Why?
|
| Muscles | 1 | 2004 | 239 | 0.010 |
Why?
|
| Syndrome | 1 | 2007 | 1175 | 0.010 |
Why?
|
| Estrogen Receptor beta | 1 | 2004 | 78 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 142 | 0.010 |
Why?
|
| Protein Structure, Quaternary | 1 | 2004 | 101 | 0.010 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2003 | 1 | 0.010 |
Why?
|
| DNA Primers | 1 | 2004 | 636 | 0.010 |
Why?
|
| Fushi Tarazu Transcription Factors | 1 | 2003 | 7 | 0.010 |
Why?
|
| Luteal Cells | 1 | 2003 | 9 | 0.010 |
Why?
|
| Aromatase | 1 | 2003 | 24 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 1831 | 0.010 |
Why?
|
| Protein Transport | 1 | 2004 | 370 | 0.010 |
Why?
|
| Mersalyl | 1 | 2003 | 1 | 0.010 |
Why?
|
| Medroxyprogesterone | 1 | 2003 | 8 | 0.010 |
Why?
|
| Cortodoxone | 1 | 2003 | 4 | 0.010 |
Why?
|
| Theca Cells | 1 | 2003 | 18 | 0.010 |
Why?
|
| Steroidogenic Factor 1 | 1 | 2003 | 36 | 0.010 |
Why?
|
| Ethinyl Estradiol | 1 | 2003 | 11 | 0.010 |
Why?
|
| Estrone | 1 | 2003 | 12 | 0.010 |
Why?
|
| Prolactin | 1 | 2003 | 113 | 0.010 |
Why?
|
| Adult | 2 | 2015 | 31614 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 1 | 2003 | 54 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2003 | 170 | 0.010 |
Why?
|
| Corticosterone | 1 | 2003 | 60 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2003 | 193 | 0.010 |
Why?
|
| Actins | 1 | 2004 | 334 | 0.010 |
Why?
|
| alpha-Fetoproteins | 1 | 2003 | 134 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 2003 | 172 | 0.010 |
Why?
|
| Prostaglandins E | 1 | 1982 | 8 | 0.010 |
Why?
|
| Diamines | 1 | 1982 | 8 | 0.010 |
Why?
|
| Epoprostenol | 1 | 1982 | 44 | 0.010 |
Why?
|
| Dinoprostone | 1 | 1982 | 70 | 0.010 |
Why?
|
| Models, Animal | 1 | 2003 | 469 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2003 | 239 | 0.010 |
Why?
|
| Phylogeny | 1 | 2004 | 763 | 0.010 |
Why?
|
| Ornithine Decarboxylase Inhibitors | 1 | 1981 | 10 | 0.010 |
Why?
|
| Exons | 1 | 2004 | 806 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 1096 | 0.010 |
Why?
|
| Thymidine | 1 | 1981 | 53 | 0.010 |
Why?
|
| Polyamines | 1 | 1981 | 31 | 0.010 |
Why?
|
| Immunosorbent Techniques | 1 | 2000 | 25 | 0.010 |
Why?
|
| Mitochondria | 1 | 2006 | 751 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2000 | 161 | 0.010 |
Why?
|
| Transcription Factor RelA | 1 | 2000 | 54 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 742 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 1224 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 761 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 589 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 1718 | 0.010 |
Why?
|
| Young Adult | 1 | 2013 | 9966 | 0.010 |
Why?
|
| Contactin 2 | 1 | 1998 | 4 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1998 | 85 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 1998 | 152 | 0.010 |
Why?
|
| Chickens | 1 | 1998 | 303 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 1998 | 157 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 1037 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 666 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1998 | 347 | 0.010 |
Why?
|
| Point Mutation | 1 | 1998 | 349 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1998 | 526 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 1350 | 0.010 |
Why?
|
| Adolescent | 1 | 2013 | 20557 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 29021 | 0.010 |
Why?
|
| Neurons | 1 | 1998 | 2015 | 0.000 |
Why?
|